Hospital de Infecciosas Francisco Javier Muniz Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04468009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital de Infecciosas Francisco Javier Muniz